Literature DB >> 12954659

A simple self-report diary for assessing psychosexual function in hypogonadal men.

Ka Kui Lee1, Nancy Berman, Gerianne M Alexander, Laura Hull, Ronald S Swerdloff, Christina Wang.   

Abstract

To examine the performance of a self-report diary to assess psychosexual function in hypogonadal men, 2 groups of eugonadal men and 2 groups of hypogonadal men were asked to record and score parameters for sexual desire, sexual enjoyment, sexual performance, sexual activity, and positive and negative moods daily for 7 days before a clinic visit (data set 1 and 2). The hypogonadal men were also assessed after testosterone replacement and some of the eugonadal men were studied while they were on placebo treatment. In this retrospective analysis, sexual function parameters (sexual desire, performance, and activity score) in the diary discriminated between the hypogonadal and eugonadal men with all measures significantly lower in hypogonadal men (all parameters P <.0001). Significant improvements in sexual desire and performance as well as sexual activity scores (P <.0001 for all parameters) in hypogonadal men after testosterone treatment were readily detected within 30 days. Mood and functional parameters did not show any change over time in eugonadal men on placebo treatment. The mood parameters assessed by the diary showed an excellent correlation with those assessed by the Profile of Mood States. Mood parameters were not clearly different between eugonadal and hypogonadal men at baseline. With testosterone treatment positive mood parameters were significantly increased (P <.0028 and.0001 set in data 1 and 2, respectively), and negative mood parameters improved in hypogonadal men (P <.0003 in data set 2). We conclude that this simple self-report diary is useful in assessing the sexual function and mood profile of hypogonadal subjects in clinical research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954659     DOI: 10.1002/j.1939-4640.2003.tb02728.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  23 in total

1.  Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.

Authors:  B D Anawalt; M Y Roth; J Ceponis; V Surampudi; J K Amory; R S Swerdloff; P Y Liu; C Dart; W J Bremner; R Sitruk-Ware; N Kumar; D L Blithe; S T Page; C Wang
Journal:  Andrology       Date:  2019-04-10       Impact factor: 3.842

Review 2.  Lower urinary tract disease: what are we trying to treat and in whom?

Authors:  Jeremy P W Heaton
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  The cerebellum in emotion regulation: a repetitive transcranial magnetic stimulation study.

Authors:  Dennis J L G Schutter; Jack van Honk
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

4.  Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Authors:  Glenn R Cunningham; Alisa J Stephens-Shields; Raymond C Rosen; Christina Wang; Shalender Bhasin; Alvin M Matsumoto; J Kellogg Parsons; Thomas M Gill; Mark E Molitch; John T Farrar; David Cella; Elizabeth Barrett-Connor; Jane A Cauley; Denise Cifelli; Jill P Crandall; Kristine E Ensrud; Laura Gallagher; Bret Zeldow; Cora E Lewis; Marco Pahor; Ronald S Swerdloff; Xiaoling Hou; Stephen Anton; Shehzad Basaria; Susan J Diem; Vafa Tabatabaie; Susan S Ellenberg; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2016-06-29       Impact factor: 5.958

5.  Lessons From the Testosterone Trials.

Authors:  Peter J Snyder; Shalender Bhasin; Glenn R Cunningham; Alvin M Matsumoto; Alisa J Stephens-Shields; Jane A Cauley; Thomas M Gill; Elizabeth Barrett-Connor; Ronald S Swerdloff; Christina Wang; Kristine E Ensrud; Cora E Lewis; John T Farrar; David Cella; Raymond C Rosen; Marco Pahor; Jill P Crandall; Mark E Molitch; Susan M Resnick; Matthew Budoff; Emile R Mohler; Nanette K Wenger; Harvey Jay Cohen; Stanley Schrier; Tony M Keaveny; David Kopperdahl; David Lee; Denise Cifelli; Susan S Ellenberg
Journal:  Endocr Rev       Date:  2018-06-01       Impact factor: 19.871

6.  Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.

Authors:  Sandeep Dhindsa; Husam Ghanim; Manav Batra; Nitesh D Kuhadiya; Sanaa Abuaysheh; Sartaj Sandhu; Kelly Green; Antoine Makdissi; Jeanne Hejna; Ajay Chaudhuri; Mark Punyanitya; Paresh Dandona
Journal:  Diabetes Care       Date:  2015-11-29       Impact factor: 19.112

7.  Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men.

Authors:  Raymond C Rosen; Alisa J Stephens-Shields; Glenn R Cunningham; Denise Cifelli; David Cella; John T Farrar; Elizabeth Barrett-Connor; Cora E Lewis; Marco Pahor; Xiaoling Hou; Peter J Snyder
Journal:  Qual Life Res       Date:  2015-09-10       Impact factor: 4.147

8.  Early Response Time in Sexual Activity and Mood Following Testosterone Gel Replacement in Hypogonadal Males from the Testim(R) START Study.

Authors:  Edward Loizides; Mark J Swierzewski; Carol O'neill; Jim Griesser; Ted Smith
Journal:  Rev Urol       Date:  2004

9.  Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism.

Authors:  Heather L Gelhorn; Margaret K Vernon; Katie D Stewart; Michael G Miller; Meryl Brod; Stanley E Althof; Leonard R DeRogatis; Adrian Dobs; Allen D Seftel; Dennis A Revicki
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

Review 10.  Topical testosterone supplementation for the treatment of male hypogonadism.

Authors:  Katrina A Abadilla; Adrian S Dobs
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.